Cargando…
Should hydrogen therapy be included in a musculoskeletal medicine routine?
Molecular hydrogen (H (2)) has recently been recognized as a potential novel therapeutic agent in biomedicine. Initially proposed to be a possible treatment for certain types of neuromuscular disorders, cardio-metabolic diseases and cancer, H (2) improved clinical end-points and surrogate markers in...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147523/ https://www.ncbi.nlm.nih.gov/pubmed/28003879 http://dx.doi.org/10.12688/f1000research.9758.1 |
| Sumario: | Molecular hydrogen (H (2)) has recently been recognized as a potential novel therapeutic agent in biomedicine. Initially proposed to be a possible treatment for certain types of neuromuscular disorders, cardio-metabolic diseases and cancer, H (2) improved clinical end-points and surrogate markers in several clinical trials, mainly acting as an anti-inflammatory agent and powerful antioxidant. In this paper, the medicinal properties of H (2) in musculoskeletal medicine are discussed with the aim to provide an updated and practical overview for health professionals working in this field. |
|---|